JP6692101B2 - Method for producing transformed earthworm and method for producing recombinant protein - Google Patents
Method for producing transformed earthworm and method for producing recombinant protein Download PDFInfo
- Publication number
- JP6692101B2 JP6692101B2 JP2018225522A JP2018225522A JP6692101B2 JP 6692101 B2 JP6692101 B2 JP 6692101B2 JP 2018225522 A JP2018225522 A JP 2018225522A JP 2018225522 A JP2018225522 A JP 2018225522A JP 6692101 B2 JP6692101 B2 JP 6692101B2
- Authority
- JP
- Japan
- Prior art keywords
- earthworm
- earthworms
- transformed
- producing
- recombinant protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000361919 Metaphire sieboldi Species 0.000 title claims description 62
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title claims description 37
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title claims description 37
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- 241001233061 earthworms Species 0.000 claims description 52
- 239000013604 expression vector Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 28
- 238000004520 electroporation Methods 0.000 claims description 14
- 206010002091 Anaesthesia Diseases 0.000 claims description 9
- 230000037005 anaesthesia Effects 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 238000000520 microinjection Methods 0.000 claims description 5
- 241000243679 Lumbricidae Species 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 4
- 238000011069 regeneration method Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 3
- 108060001084 Luciferase Proteins 0.000 description 13
- 239000005089 Luciferase Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- 230000003248 secreting effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001495098 Lumbricus rubellus Species 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000254158 Lampyridae Species 0.000 description 2
- 108010047357 Luminescent Proteins Proteins 0.000 description 2
- 102000006830 Luminescent Proteins Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000003969 blast cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000002352 surface water Substances 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 241000426529 Eisenia andrei Species 0.000 description 1
- 241000243686 Eisenia fetida Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- -1 ndrei Species 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、形質転換ミミズの作成方法及び組み換えタンパク質の生産方法に関するものである。 The present invention relates to a method for producing a transformed earthworm and a method for producing a recombinant protein.
遺伝子工学を利用した組み換えタンパク質の生産は、微生物、特に大腸菌を中心に行われているが、動物由来の組み換えタンパク質の生産に関しては、糖鎖修飾等のため微生物で発現させ、活性有る状態で取得することは困難であり、そのため、従来は、培養細胞やヤギ等の高等動物(哺乳動物)の遺伝子組み換え家畜を用いて活性体の生産が試みられている。 Recombinant proteins are produced using genetic engineering mainly in microorganisms, especially Escherichia coli, but regarding the production of recombinant proteins derived from animals, they are expressed in microorganisms for sugar chain modification etc. and obtained in an active state. Therefore, it has been conventionally attempted to produce an active form using genetically modified livestock of cultured cells or higher animals (mammals) such as goats.
しかしながら、これらの手法は、煩雑であるうえに微生物を用いた場合に比べコスト高であるという問題があり、また、組み換えタンパク質を効率良く生産回収するには、体内で生産した組み換えタンパク質を液体で細胞外へ分泌させそれを回収するのが最も効率が良いと考えられるが、微生物以外で分泌回収システムを構築することは非常に困難であるため、安価で簡便な組み換えタンパク質の生産方法の提案が望まれていた。 However, these methods have a problem that they are complicated and costly as compared with the case of using a microorganism, and in order to efficiently produce and recover the recombinant protein, the recombinant protein produced in the body is liquid. It is considered that the most efficient method is to secrete extracellularly and recover it, but it is extremely difficult to construct a secretory recovery system other than microorganisms, so a cheap and convenient method for producing recombinant proteins has been proposed. Was wanted.
このような状況の中、近年、特許文献1に示すような、ミミズを用いた組み換えタンパク質の生産方法が提案されている。 Under such circumstances, in recent years, a method for producing a recombinant protein using earthworms has been proposed as shown in Patent Document 1.
この特許文献1では、ミミズの生殖巣を含む前半部を切断した後、再生を誘導して再生芽細胞を形成させ、再生初期にミミズの再生芽細胞部位に組み換え遺伝子発現ベクターを注入して形質転換されたミミズを作成し、この形質転換ミミズが生産する組み換えタンパク質をミミズ破砕液と共に回収することで、簡便に組み換えタンパク質が得ることが示されている。 In this Patent Document 1, after cutting the first half of the earthworm including the gonad, regeneration is induced to form regenerated blast cells, and a recombinant gene expression vector is injected into the regenerated blast cell site of the earthworm at the early stage of regeneration to induce traits. It has been shown that a recombinant protein can be easily obtained by preparing a transformed earthworm and recovering the recombinant protein produced by this transformed earthworm together with the crushed solution of the earthworm.
しかしながら、実際にはベクターを生殖巣に直接注入する操作は、非常に難しく熟練を要する操作であり、誰もが容易にできるものではなかった。 However, actually, the operation of directly injecting the vector into the gonad is extremely difficult and requires skill, and cannot be easily performed by anyone.
また、組み換えタンパク質回収時にミミズを死滅させてしまうため、連続的に効率良く組み換えタンパク質を生産・回収することができなかった。 Moreover, since the earthworms are killed when the recombinant protein is recovered, it has been impossible to continuously and efficiently produce and recover the recombinant protein.
本発明は、上述のような従来技術の問題に鑑みなされたものであり、極めて容易に組み換えタンパク質を生産することができる形質転換ミミズの作成方法及び組み換えタンパク質の生産方法を提供することを目的とする。 The present invention has been made in view of the problems of the conventional techniques as described above, and an object of the present invention is to provide a method for producing a transformed earthworm and a method for producing a recombinant protein that can extremely easily produce a recombinant protein. To do.
添付図面を参照して本発明の要旨を説明する。 The gist of the present invention will be described with reference to the accompanying drawings.
ツリミミズ科(Lumbricidae)に属するミミズを長さ方向途中で切断するか若しくは切り込みを入れ、このミミズに麻酔処理を施し、前記麻酔が作用している状態で前記切断若しくは前記切り込みによって生成される再生切断面に目的遺伝子が発現するように構築した発現ベクターを注入し電気穿孔法を用いてこの発現ベクターを細胞内若しくはゲノム内に導入して前記ミミズを形質転換させることを特徴とする形質転換ミミズの作成方法に係るものである。 Earthworms belonging to the Lumbricidae family are cut or incised in the lengthwise direction, and this earthworm is anesthetized, and the cutting or regeneration cutting generated by the incision while the anesthesia is operating. Of the transformed earthworm characterized by injecting an expression vector constructed so that the target gene is expressed on the surface and transforming the earthworm by introducing this expression vector into cells or genome using electroporation It relates to the creation method.
また、請求項1記載の形質転換ミミズの作成方法において、前記発現ベクターをマイクロインジェクション法により注入することを特徴とする形質転換ミミズの作成方法に係るものである。 The method for producing a transformed earthworm according to claim 1 , wherein the expression vector is injected by a microinjection method.
また、食用に供されるツリミミズ科(Lumbricidae)に属するミミズを長さ方向途中で切断するか若しくは切り込みを入れ、このミミズに麻酔処理を施し、前記麻酔が作用している状態で前記切断若しくは前記切り込みによって生成される再生切断面に目的遺伝子が発現するように構築した発現ベクターをマイクロインジェクション法により注入し電気穿孔法を用いてこの発現ベクターを細胞内若しくはゲノム内に導入して前記ミミズを形質転換させることを特徴とする形質転換ミミズの作成方法に係るものである。 In addition, earthworms belonging to the earthworm earthworm (Lumbricidae) to be used for food are cut or cut in the middle of the length direction, anesthesia treatment is given to this earthworm, and the cutting or the above in the state where the anesthesia is operating An expression vector constructed so that the gene of interest is expressed on the regenerated cut surface generated by cutting is injected by the microinjection method, and this expression vector is introduced into the cell or the genome using the electroporation method to transform the earthworm. The present invention relates to a method for producing a transformed earthworm which is characterized in that it is transformed.
また、請求項1〜3いずれか1項に記載の形質転換ミミズの作成方法を用いて所定の組み換えタンパク質を生産することを特徴とする組み換えタンパク質の生産方法に係るものである。 Further, the present invention relates to a method for producing a recombinant protein, which comprises producing a predetermined recombinant protein by using the method for producing a transformed earthworm according to any one of claims 1 to 3 .
本発明は上述のようにしたから、極めて容易に目的遺伝子を発現する形質転換ミミズを作成することができ、この形質転換ミミズを用いて容易に組み換えタンパク質を効率良く得る(生産する)ことができる画期的な形質転換ミミズの作成方法及び組み換えタンパク質の生産方法となる。 INDUSTRIAL APPLICABILITY Since the present invention has been described above, a transformed earthworm that expresses a gene of interest can be produced very easily, and a recombinant protein can be easily and efficiently obtained (produced) using this transformed earthworm. It is a groundbreaking method for producing transformed earthworms and a method for producing recombinant proteins.
好適と考える本発明の実施形態を、図面に基づいて本発明の作用を示して簡単に説明する。 A preferred embodiment of the present invention will be briefly described with reference to the drawings showing the operation of the present invention.
本発明は、まず、ミミズに発現ベクターを注入する。この注入方法に関しては、特に限定するものではなく、例えばマイクロシリンジやマイクロインジェクター等の注入器具を用い、ミミズの環帯と尾部とに各々注入したり、ミミズを所定部位で切断し、この切断面付近に注入する等の方法がある。 In the present invention, the expression vector is first injected into the earthworm. This injection method is not particularly limited, and for example, using an injection device such as a microsyringe or a microinjector, each is injected into the annulus and tail of the earthworm, or the earthworm is cut at a predetermined site, and the cut surface is cut. There is a method such as injection in the vicinity.
続いて、この注入した発現ベクターを、細胞内若しくはゲノムに導入してミミズを形質転換させる。本発明では、電気穿孔法を用い、細胞に微小な孔を穿設し、この孔から発現ベクターを導入する方法を用いる。 Subsequently, the injected expression vector is introduced into cells or the genome to transform earthworms. In the present invention, a method in which a micropore is formed in a cell using an electroporation method and an expression vector is introduced from this hole is used.
具体的には、例えばエレクトロポレーターを用い、処理条件を、電圧5〜100V(好ましくは10〜40V、より好ましくは28V)、処理時間5〜300msec(好ましくは10〜120msec、より好ましくは60msec)、パルス1〜20回/秒(好ましくはパルス3〜10回/秒、より好ましくは6回/秒)に設定して行う。 Specifically, for example, using an electroporator, the treatment conditions are a voltage of 5 to 100 V (preferably 10 to 40 V, more preferably 28 V), a treatment time of 5 to 300 msec (preferably 10 to 120 msec, more preferably 60 msec). The pulse is set to 1 to 20 times / sec (preferably 3 to 10 times / sec, more preferably 6 times / sec).
この電気穿孔法を用いて細胞内に発現ベクターを導入した後、所定の温湿度で管理された環境下で所定期間飼育することで目的遺伝子が発現する形質転換ミミズを得ることができ、この形質転換ミミズを用いることで所定の組み換えタンパク質を得ることができる。 After introducing an expression vector into cells using this electroporation method, a transformed earthworm expressing the target gene can be obtained by breeding for a predetermined period in an environment controlled at a predetermined temperature and humidity. A predetermined recombinant protein can be obtained by using the converted earthworm.
尚、本発明において、形質転換させるミミズは、特に限定するものは無く全てのミミズを用いることが可能であるが、例えばツリミミズ科のシマミミズやアンドレイミミズやアカミミズは、体長5〜10cmと適度な大きさでタンパク質生産能力にも優れ、また、日本で多く養殖されていて容易に入手できると共に非常に安価であるため、これらを用いると特に良い。 In the present invention, the earthworms to be transformed are not particularly limited and it is possible to use all earthworms. For example, the earthworm earthworms and Andrei earthworms and red earthworms of the family earthworms have an appropriate size of 5 to 10 cm in length. It is particularly preferable to use these because they are excellent in protein production capacity, and because they are cultivated in large numbers in Japan, are easily available, and are extremely inexpensive.
また、例えば電気穿孔法を施す前にミミズに麻酔処理を施すと良く、この麻酔処理を施すことによって、電気穿孔法を行なう際にミミズが暴れず、スムーズに処理を行なうことができる。 Further, for example, the earthworms may be anesthetized before the electroporation method. By performing the anesthesia processing, the earthworms can be treated smoothly without performing the electroporation method.
本発明の具体的な実施例について説明する。 Specific examples of the present invention will be described.
本実施例は、発現ベクターを細胞内若しくはゲノムに導入することで組み換えタンパク質を分泌生産するミミズを得、このミミズを用いて所定の組み換えタンパク質を得ることができるシステムに関するものである。 The present example relates to a system capable of obtaining an earthworm that secretes and produces a recombinant protein by introducing an expression vector into a cell or a genome, and using the earthworm, a predetermined recombinant protein can be obtained.
以下、本実施例について詳細に説明する。 Hereinafter, this example will be described in detail.
[形質転換ミミズの作成]
本実施例では、形質転換させるミミズに、シマミミズ(Eisenia fetida)を用い、具体的には、24〜48時間絶食させたものを用いる。
[Creation of transformed earthworm]
In the present example, the earthworms to be transformed are the earthworms (Eisenia fetida), and specifically, the ones fasted for 24 to 48 hours are used.
より具体的には、本実施例では、重金属を含まない飼料で食用として飼育したミミズ(詳細には特許第5505750号に記載の方法で飼育したミミズ)を用いた。 More specifically, in this example, earthworms cultivated for food with heavy metal-free feed (specifically, earthworms cultivated by the method described in Japanese Patent No. 5505750) were used.
尚、採用するミミズは上記に限らず、例えば同じツリミミズ科に属するアンドレイミミズ(Eisenia andrei)やアカミミズ(Lumbricus rubellus)でも良い。 The earthworms to be adopted are not limited to the above, and may be, for example, Eisenia andrei and red earthworms (Lumbricus rubellus) belonging to the same earthworm family.
本実施例では、このシマミミズを尾部から約1cmのところで切断し、この切断した尾部を滅菌水で湿らせたウエスを敷いた容器内に入れ、人工気象器で所定の温湿度環境下のもと、具体的には、温度15〜30℃(本実施例では21℃に設定)、湿度50〜90%(本実施例では70%に設定)の環境下のもと、4〜48時間(本実施例では24時間)飼育した。 In this example, the earthworms were cut at a distance of about 1 cm from the tail, and the cut tail was placed in a container lined with a sterilized water-wet cloth. Specifically, under an environment of a temperature of 15 to 30 ° C. (set to 21 ° C. in this embodiment) and a humidity of 50 to 90% (set to 70% in this embodiment), 4 to 48 hours (book) They were bred for 24 hours in the examples).
本実施例では、この所定環境で飼育したミミズを3%エタノール溶液(液温4℃)中に10分程度放置してこのミミズに麻酔処理を施し、この麻酔が作用した状態で発現ベクターを注入した。 In this example, earthworms bred in this predetermined environment were left in a 3% ethanol solution (solution temperature 4 ° C.) for about 10 minutes to anesthetize the earthworms, and the expression vector was injected while the anesthesia acted. did.
具体的には、従来法であるマイクロインジェクション法を用いて、切断したミミズの尾部の再生切断面付近に、ルシフェラーゼ発現ベクター(pGL4.50)を注入した。 Specifically, the luciferase expression vector (pGL4.50) was injected near the regenerated cut surface of the tail of the cut earthworm using the conventional microinjection method.
続いて、電気穿孔法を用いて、この注入したルシフェラーゼ発現ベクターをミミズの細胞内(若しくはベクター)に導入した。 Then, this injected luciferase expression vector was introduced into the cell (or vector) of the earthworm by electroporation.
具体的には、エレクトロポレーター(BTX社製 BTX45-2007 GEMINI X2 System)を用いて、電圧:28V、処理時間:60msec、パルス:6回/秒の条件でミミズに電気ショックを与え、ルシフェラーゼ発現ベクターをミミズに導入した。 Specifically, using an electroporator (BTX45-2007 GEMINI X2 System manufactured by BTX), electric shock was applied to earthworms under the conditions of voltage: 28 V, treatment time: 60 msec, pulse: 6 times / second, and luciferase expression. The vector was introduced into the earthworm.
その後、温度15〜30℃(本実施例では21℃)、湿度50〜90%(本実施例では70%)に設定した人工気象器にミミズを入れ、24〜72時間(本実施例では68時間)飼育し、この飼育したミミズを形質転換ミミズとして得た。 Then, earthworms were placed in an artificial weather device set to a temperature of 15 to 30 ° C. (21 ° C. in this embodiment) and a humidity of 50 to 90% (70% in this embodiment) for 24 to 72 hours (68 in this embodiment). For a period of time) and the thus-raised earthworms were obtained as transformed earthworms.
[ルシフェラーゼ活性測定]
本実施例では、上述のようにして作成した形質転換ミミズが、実際にルシフェラーゼ発現ベクターが導入され、形質転換されたかどうかを確認するため、ルシフェラーゼ活性測定を行なった。尚、本実施例では、上述の条件で作成したミミズの他に、電気穿孔法における電圧条件を14Vに設定して作成したミミズ(14V条件ミミズ)と、組み換えタンパク質(ルシフェラーゼ)が発現しない空ベクターを注入し、上記形質転換ミミズの作成方法を同様の処理を行ったミミズ(コントロールミミズ)とを比較対象として用意し、これらも合わせてルシフェラーゼ活性測定を行なった。
[Luciferase activity measurement]
In this Example, luciferase activity was measured to confirm whether the transformed earthworms prepared as described above were actually transformed with the luciferase expression vector. In this example, in addition to the earthworms prepared under the above-mentioned conditions, earthworms prepared by setting the voltage condition in the electroporation method to 14V (14V condition earthworms) and empty vector in which the recombinant protein (luciferase) was not expressed. Was prepared and the above-mentioned method for producing transformed earthworms was prepared as a comparison target with earthworms (control earthworms) treated in the same manner, and the luciferase activity was also measured.
ルシフェラーゼ活性測定は、具体的には、形質転換させた断片及び比較対象の断片の各々の重量を測定した後、各断片を細胞溶解液(Luciferase Assay System,プロメガ社製)、ビーズを含むスクリューキャップチューブに添加し、これを細胞破砕装置にセットして、4200回転、20秒の処理条件で5回、破砕処理を行った後、遠心し上清液を取得し、この上清液にルシフェリン(Luciferase Assay System,プロメガ社製)を添加し、ルミノメーター(GloMax-Multi detection System,プロメガ社製)を用いて発光を測定した。 Specifically, the luciferase activity was measured by measuring the weight of each of the transformed fragment and the fragment to be compared, and then measuring each fragment with a cell lysate (Luciferase Assay System, manufactured by Promega) and a screw cap containing beads. The mixture was added to a tube, set in a cell disruption device, disrupted 5 times under a treatment condition of 4200 rpm for 20 seconds, and then centrifuged to obtain a supernatant liquid. Luciferin ( Luciferase Assay System, manufactured by Promega) was added, and luminescence was measured using a luminometer (GloMax-Multi detection System, manufactured by Promega).
その結果、図1に示すように、本実施例で示した方法(電気穿孔法における電圧条件が28V)で形質転換を行なったミミズだけに、時間と共に発光強度が減少して行く傾向が見られ、これより、ルシフェラーゼ発現ベクターが導入され形質転換され組み換えタンパク質が発現していることが確認できた。 As a result, as shown in FIG. 1, only the earthworms transformed by the method shown in this Example (voltage condition in electroporation was 28 V) showed a tendency that the luminescence intensity decreased with time. From this, it was confirmed that the luciferase expression vector was introduced and transformed to express the recombinant protein.
このように、本実施例に示した形質転換ミミズの作成方法により、熟練者でなくても極めて容易に形質転換ミミズを作成することができ、この形質転換ミミズを用いれば、極めて容易に組み換えタンパク質を得ることができる。 As described above, by the method for producing a transformed earthworm shown in this example, even an unskilled person can produce a transformed earthworm very easily. By using this transformed earthworm, the recombinant protein can be extremely easily produced. Can be obtained.
尚、本実施例では、尾部から約1cmのところで切断し、この切断したミミズの尾部の再生切断面付近に、発現ベクター(ルシフェラーゼ発現ベクター)を注入したが、例えば完全に切断せず、カッター等で切込みを入れ、この切込みに発現ベクターを注入しても良いし、或いは切断処理を行わず、非切断状態のミミズの所定部位(例えば尾部や環帯付近)に発現ベクターを注入しても良い。 In addition, in the present Example, a cut was made at about 1 cm from the tail, and an expression vector (luciferase expression vector) was injected near the regenerated cut surface of the cut tail of the earthworm. You may inject the expression vector into the incision and inject the expression vector into this incision, or you may inject the expression vector into a predetermined site (for example, near the tail or annulus) of the non-cleaved earthworm without performing the cleavage treatment. ..
[組み換えタンパク質の取得方法]
本実施例に示した形質転換ミミズの作成方法で作成した形質転換ミミズが生産する組み換えタンパク質の取得方法について、以下に説明する。
[How to obtain recombinant protein]
The method for obtaining the recombinant protein produced by the transformed earthworm produced by the method for producing the transformed earthworm shown in the present example will be described below.
ミミズがタンパク質あるいはペプチドを分泌生産することは従来知られている。従って、この形質転換ミミズからも所定の組み換えタンパク質が分泌生産されていると言える。 It is conventionally known that earthworms secrete and produce proteins or peptides. Therefore, it can be said that a predetermined recombinant protein is secreted and produced also from this transformed earthworm.
従って、本実施例では、この形質転換ミミズが分泌する体腔液を回収することで、組み換えタンパク質を取得した。 Therefore, in this example, the recombinant protein was obtained by collecting the body cavity fluid secreted by the transformed earthworm.
具体的には、先ず、形質転換ミミズを水洗いして体表の汚物等を除去し、その後、ミミズを死滅させない程度の濃度に調整した有機溶媒(例えばエタノール)または、酸若しくはアルカリを少量滴下し、体腔液を分泌させ、この分泌した体腔液を回収した。 Specifically, first, the transformed earthworms are washed with water to remove dirt and the like on the body surface, and then a small amount of an organic solvent (for example, ethanol) adjusted to a concentration that does not kill the earthworms or an acid or alkali is dropped. The body cavity fluid was secreted, and the secreted body cavity fluid was recovered.
より具体的には、先ず、対象の形質転換ミミズを26時間絶食させ、その後純水で洗浄して体表の汚物を除去した後、表面の水分を除去した。 More specifically, first, the target transformed earthworms were fasted for 26 hours, and then washed with pure water to remove body surface contaminants, and then surface water was removed.
続いて、15mlファルコンチューブに25mM NaCl含有50mM リン酸ナトリウム緩衝液(pH7.0)1mlを加え、この中に準備した形質転換ミミズ5匹を加え、撹拌混合(20sec)して粘液を除去した後、ファルコンチューブから取り出し、水洗し、再び、表面の水分を除去した。 Subsequently, 1 ml of 50 mM sodium phosphate buffer (pH 7.0) containing 25 mM NaCl was added to a 15 ml falcon tube, and 5 prepared transformed earthworms were added thereto, and the mixture was stirred and mixed (20 sec) to remove mucus. Then, it was taken out from the Falcon tube, washed with water, and the surface water was removed again.
続いて、この形質転換ミミズを、15mlファルコンチューブに入れ、0.1M 酢酸ナトリウム緩衝液(pH3.5)5.0μlを加えた後、再度、ファルコンチューブから形質転換ミミズを取り出し、遠心分離処理(4℃、6000回転、15分)し、この処理後の上清液をエッペンチューブに取り、この上清液を遠心分離処理(4℃、14000回転、10分)し、更にこの処理後の上清液をエッペンチューブに取り、再度遠心分離処理(4℃、14000回転、5分)し、この遠心分離処理にて得られた上清液を分泌液として回収し、組み換えタンパク質を得た。 Subsequently, this transformed earthworm was placed in a 15 ml Falcon tube, 5.0 μl of 0.1 M sodium acetate buffer (pH 3.5) was added, and then the transformed earthworm was again taken out from the Falcon tube and subjected to centrifugation treatment ( 4 ° C., 6000 rpm, 15 minutes), collect the supernatant after this treatment into an Eppendorf tube, centrifuge the supernatant (4 ° C., 14000 rpm, 10 minutes), and further after this treatment The clear liquid was placed in an Eppendorf tube and centrifuged again (4 ° C., 14000 rpm, 5 minutes), and the supernatant obtained by this centrifugation was recovered as a secreted liquid to obtain a recombinant protein.
尚、0.1M 酢酸ナトリウム緩衝液(pH3.5)5.0μlを加えた後、ファルコンチューブから取り出した形質転換ミミズは、水洗いすることで死滅することなく再び活動を始めることを確認した。即ち、上記方法で分泌液を回収することで、形質転換ミミズを死滅させることなく連続的に分泌液を回収することができることとなる。 After the addition of 5.0 μl of 0.1 M sodium acetate buffer (pH 3.5), it was confirmed that the transformed earthworms taken out from the Falcon tube were washed again with water to start their activity again without being killed. That is, by collecting the secretion liquid by the above method, it is possible to continuously collect the secretion liquid without killing the transformed earthworm.
また、体腔液を分泌させる方法に関しては、上述した方法以外に、例えばミミズに熱風やインキュベータを用いてミミズが死滅しない程度の熱刺激(0℃〜4℃程度の低温刺激や30℃〜40℃程度の中温刺激)を付与したり、太陽光に曝して紫外線を照射する刺激を付与したり、白熱灯等を用いて強光を照射する刺激を付与したり、ミミズが死滅しない薬物(例えば重層)による刺激を付与したり、或いはこれらの刺激を含む他の刺激を付与して、体腔液を分泌させても良く、本実施例に限られるものではない。 Regarding the method of secreting body cavity fluid, in addition to the method described above, for example, heat stimulation to earthworms using hot air or an incubator to such an extent that the earthworms are not killed (low temperature stimulation of 0 ° C to 4 ° C or 30 ° C to 40 ° C). Drugs that do not kill earthworms (for example, multi-layered), given a stimulus of irradiating ultraviolet rays by exposing to sunlight, giving a stimulus of emitting strong light using an incandescent lamp, etc. ), Or other stimuli including these stimuli may be applied to secrete body cavity fluid, and the present invention is not limited to this example.
また、本実施例は、形質転換させるミミズに、食用ミミズを採用したから、上述のように分泌液と共に組み換えタンパク質を回収する方法以外に、形質転換ミミズそのものを摂取することで、組み換えタンパク質を摂取することも可能である。 Further, in this example, since edible earthworms were adopted as the earthworms to be transformed, in addition to the method of recovering the recombinant protein together with the secretory fluid as described above, ingestion of the transformed earthworms themselves resulted in ingestion of the recombinant protein. It is also possible to do so.
上述した本実施例の作用・効果について以下に説明する。 The operation and effect of this embodiment described above will be described below.
本実施例は、形質転換させるミミズに、ツリミミズ科のシマミミズを採用するから、安価で入手し易く、低コスト化が実現可能となる。 In the present example, since the earthworms of the family Lamiaceae are adopted as the earthworms to be transformed, they can be obtained at low cost, easily and at low cost.
また、本実施例は、ミミズを形質転換させる際に、電気穿孔法を用いて注入した発現ベクターを細胞内若しくはゲノムに導入するから、熟練者でなくても極めて容易に発現ベクターを細胞内に導入でき、ミミズを形質転換させることができる。 Further, in this example, when transforming an earthworm, since the expression vector injected using the electroporation method is introduced into the cell or the genome, even an unskilled person can very easily introduce the expression vector into the cell. It can be introduced and transformed into earthworms.
しかも、本実施例は、このミミズに電気穿孔法を施す前に、ミミズに麻酔処理を施し、麻酔が効いている状態で電気穿孔法を行なうので、ミミズが暴れず、作業がし易い。 Moreover, in this embodiment, since the earthworm is anesthetized before the electroporation method is applied to the earthworm and the electroporation method is performed while the anesthesia is effective, the earthworm is not violent and the work is easy.
また、本実施例は、組み換えタンパク質を分泌回収する際、形質転換ミミズを死滅させないので、分泌液の連続回収が可能となり効率的な組み換えタンパク質の分泌回収システムの構築が可能となる。 Further, in this example, when the recombinant protein is secreted and recovered, the transformed earthworms are not killed, so that the secretory fluid can be continuously recovered, and an efficient recombinant protein secretory recovery system can be constructed.
更に、本実施例は、このミミズに食用ミミズを採用するから、組み換えタンパク質の取得が分泌液による回収取得に限らず、分泌回収することなく、そのまま形質転換ミミズを摂取することで組み換えタンパク質を摂取することも可能となり、分泌回収の手間が省ける。 Furthermore, in this example, since the edible earthworm is adopted as this earthworm, the recombinant protein is not limited to the collection and acquisition by the secretory fluid, and the recombinant earthworm is ingested as it is without injecting and recovering the transformed earthworm. It is also possible to save the labor of secretory collection.
また、分泌液を回収する場合も、ミミズを死滅させることなく回収できるから、組み換えタンパク質を連続的に生産・回収することができる。 Also, when the secretory fluid is recovered, it can be recovered without killing the earthworms, so that the recombinant protein can be continuously produced and recovered.
以上、本実施例においては、シマミミズ等にルシフェラーゼ発現ベクターを導入することで蛍由来発光酵素の主成分となる発光タンパク質を生産するミミズが得られ、これにより、蛍由来発光酵素の主成分となる発光タンパク質を簡易に且つ効率良く得ることが可能となる。 As described above, in the present example, an earthworm that produces a photoprotein that is the main component of the firefly-derived luminescent enzyme was obtained by introducing the luciferase expression vector into the earthworm, etc., and thus the main component of the firefly-derived luminescent enzyme was obtained. It becomes possible to easily and efficiently obtain the photoprotein.
尚、本発明は、本実施例に限られるものではなく、各構成要件の具体的構成は適宜設計し得るものである。 It should be noted that the present invention is not limited to this embodiment, and the specific constitution of each constituent element can be designed as appropriate.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018225522A JP6692101B2 (en) | 2018-11-30 | 2018-11-30 | Method for producing transformed earthworm and method for producing recombinant protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018225522A JP6692101B2 (en) | 2018-11-30 | 2018-11-30 | Method for producing transformed earthworm and method for producing recombinant protein |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014212692A Division JP6448294B2 (en) | 2014-10-17 | 2014-10-17 | Method for producing transformed earthworm, method for producing recombinant protein, and method for recovering recombinant protein |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019050827A JP2019050827A (en) | 2019-04-04 |
JP6692101B2 true JP6692101B2 (en) | 2020-05-13 |
Family
ID=66013146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018225522A Active JP6692101B2 (en) | 2018-11-30 | 2018-11-30 | Method for producing transformed earthworm and method for producing recombinant protein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6692101B2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0947233A (en) * | 1995-05-30 | 1997-02-18 | Teizo Yamaji | Scattering bait for fish gathering having slow disintegration in sea water formulated in dried solid |
KR101235297B1 (en) * | 2009-10-22 | 2013-02-20 | (주)에코젠크래프트 | Method for preparing transgenic earthworm using germ plasm reproductive ability of earthworm, transgenic earthworm prepared thereby, and process for producing recombinant protein from body fluid of transgenic earthworm |
JP4713671B1 (en) * | 2010-01-22 | 2011-06-29 | ネッパジーン株式会社 | Foreign gene transfer by electroporation |
-
2018
- 2018-11-30 JP JP2018225522A patent/JP6692101B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019050827A (en) | 2019-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tanaka et al. | Expanding the repertoire of optogenetically targeted cells with an enhanced gene expression system | |
Park et al. | Targeted ablation of CCAP neuropeptide-containing neurons of Drosophila causes specific defects in execution and circadian timing of ecdysis behavior | |
Diao et al. | Neuromodulatory connectivity defines the structure of a behavioral neural network | |
EP2581446B1 (en) | Method for producing pentameric crp, pentameric crp-producing transgenic silkworm and method for constructing same, dna encoding canine monomeric crp and expression vector containing the dna | |
JP6448294B2 (en) | Method for producing transformed earthworm, method for producing recombinant protein, and method for recovering recombinant protein | |
Wang et al. | A comprehensive review on genetically modified fish: key techniques, applications and future prospects | |
JP6692101B2 (en) | Method for producing transformed earthworm and method for producing recombinant protein | |
Walker et al. | Genetics of behavior in C. elegans | |
Coutinho-Abreu et al. | Technological advances in mosquito olfaction neurogenetics | |
Okada et al. | Toxocara cati larval migration to mouse fetuses through transplacental infection | |
DE3682482D1 (en) | METHOD FOR PRODUCING A RABBIT VACCINE AND VACCINE OBTAINED BY THIS PROCESS. | |
Lu et al. | Genetic analysis of synaptogenesis | |
KR20140046599A (en) | Foreign protein expression system in insect cells using aedes aegypti vitellogenin promoter and protein promoting transcription activity | |
CN107955818A (en) | A kind of method for building up of non-human primate neurological disease animal model and application thereof | |
DE60314017T2 (en) | CHIMERIC PROTEIN CONTAINS THE CYSTEIN PROTEASE FROM THE LARGE LIVERGEL FUSIONED TO THE HEPATITIS B CORE PROTEIN OR UBIQUITIN; PLANTS EXPRESSING THIS PROTEIN, AND THEIR USE AS VACCINE | |
CN103276016A (en) | Variety breeding method of special silkworm for secreting medical silk | |
Chalasani | Characterisation and expression of the DAF-12-like nuclear hormone receptor of the parasitic nematode Parastrongyloides trichosuri | |
Kohandel | Intestinal Immunolocalization and Insight on the Role of Tachykinin-Related Peptides in the Yellow Fever Mosquito, Aedes aegypti | |
US2784142A (en) | Process for the recovery of callicrein from animal substances | |
Conway et al. | Fluorescent tagged analysis of neural gene function using mosaics in zebrafish and Xenopus laevis | |
JP6764072B2 (en) | How to make fish soy sauce | |
Sinner | Signaling Mechanisms Behind the Benefits of Sleep | |
Yumita | Cholinergic and Photoreceptive Pathways that Regulate Sleep in Drosophila melanogaster | |
Pearce et al. | PiggyBac mediated transgenesis and CRISPR/Cas9 knockout in the greater waxmoth, Galleria mellonella | |
CN115927352A (en) | Construction method and application of ARHGAP11B transgenic zebra fish model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181217 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190606 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190809 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200107 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200305 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200331 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6692101 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |